These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1-CX3CR1 signaling in a mouse model of retinitis pigmentosa. Zabel MK, Zhao L, Zhang Y, Gonzalez SR, Ma W, Wang X, Fariss RN, Wong WT. Glia; 2016 Sep; 64(9):1479-91. PubMed ID: 27314452 [Abstract] [Full Text] [Related]
6. Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1 axis in a Niemann-Pick disease type C1 model. Seo Y, Kim HS, Kang I, Choi SW, Shin TH, Shin JH, Lee BC, Lee JY, Kim JJ, Kook MG, Kang KS. Glia; 2016 Dec; 64(12):2291-2305. PubMed ID: 27687148 [Abstract] [Full Text] [Related]
7. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ, Muñetón-Gómez V, Alvárez MI, Toledano-Díaz A. Curr Alzheimer Res; 2016 Dec; 13(4):403-12. PubMed ID: 26567742 [Abstract] [Full Text] [Related]
8. Role of MSK1 in the Induction of NF-κB by the Chemokine CX3CL1 in Microglial Cells. Galán-Ganga M, García-Yagüe ÁJ, Lastres-Becker I. Cell Mol Neurobiol; 2019 Apr; 39(3):331-340. PubMed ID: 30830503 [Abstract] [Full Text] [Related]
9. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Maphis N, Xu G, Kokiko-Cochran ON, Jiang S, Cardona A, Ransohoff RM, Lamb BT, Bhaskar K. Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819 [Abstract] [Full Text] [Related]
10. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease. Castro-Sánchez S, García-Yagüe ÁJ, López-Royo T, Casarejos M, Lanciego JL, Lastres-Becker I. Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735 [Abstract] [Full Text] [Related]
11. Regulation of tau pathology by the microglial fractalkine receptor. Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, Lamb BT. Neuron; 2010 Oct 06; 68(1):19-31. PubMed ID: 20920788 [Abstract] [Full Text] [Related]
12. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Lee S, Varvel NH, Konerth ME, Xu G, Cardona AE, Ransohoff RM, Lamb BT. Am J Pathol; 2010 Nov 06; 177(5):2549-62. PubMed ID: 20864679 [Abstract] [Full Text] [Related]
13. Cx3cr1-deficient microglia exhibit a premature aging transcriptome. Gyoneva S, Hosur R, Gosselin D, Zhang B, Ouyang Z, Cotleur AC, Peterson M, Allaire N, Challa R, Cullen P, Roberts C, Miao K, Reynolds TL, Glass CK, Burkly L, Ransohoff RM. Life Sci Alliance; 2019 Dec 06; 2(6):. PubMed ID: 31792059 [Abstract] [Full Text] [Related]
14. Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy. Cuadrado A, Kügler S, Lastres-Becker I. Redox Biol; 2018 Apr 06; 14():522-534. PubMed ID: 29121589 [Abstract] [Full Text] [Related]
15. The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice. Yu YW, Li MX, Zhang ZY, Yu H. Int J Mol Med; 2018 Jun 06; 41(6):3577-3585. PubMed ID: 29568873 [Abstract] [Full Text] [Related]
16. CX3CL1/CX3CR1 axis attenuates early brain injury via promoting the delivery of exosomal microRNA-124 from neuron to microglia after subarachnoid hemorrhage. Chen X, Jiang M, Li H, Wang Y, Shen H, Li X, Zhang Y, Wu J, Yu Z, Chen G. J Neuroinflammation; 2020 Jul 14; 17(1):209. PubMed ID: 32664984 [Abstract] [Full Text] [Related]
17. LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways. Ma B, Xu L, Pan X, Sun L, Ding J, Xie C, Koliatsos VE, Cai H. Hum Mol Genet; 2016 Aug 15; 25(16):3515-3523. PubMed ID: 27378696 [Abstract] [Full Text] [Related]